Zynga (ZNGA) & NantHealth (NH) Head-To-Head Analysis

Zynga (NASDAQ:ZNGA) and NantHealth (NASDAQ:NH) are both consumer discretionary companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, institutional ownership, valuation and profitability.

Risk & Volatility

Zynga has a beta of 0.43, meaning that its stock price is 57% less volatile than the S&P 500. Comparatively, NantHealth has a beta of 0.86, meaning that its stock price is 14% less volatile than the S&P 500.


This table compares Zynga and NantHealth’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Zynga 1.70% 1.14% 0.91%
NantHealth -185.22% -116.23% -40.69%

Institutional and Insider Ownership

79.0% of Zynga shares are owned by institutional investors. Comparatively, 5.3% of NantHealth shares are owned by institutional investors. 11.9% of Zynga shares are owned by insiders. Comparatively, 64.9% of NantHealth shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Valuation and Earnings

This table compares Zynga and NantHealth’s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Zynga $907.21 million 4.66 $15.45 million $0.02 245.00
NantHealth $86.68 million 0.76 -$175.21 million ($1.12) -0.54

Zynga has higher revenue and earnings than NantHealth. NantHealth is trading at a lower price-to-earnings ratio than Zynga, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Zynga and NantHealth, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Zynga 2 1 8 0 2.55
NantHealth 0 1 2 0 2.67

Zynga presently has a consensus price target of $4.98, indicating a potential upside of 1.63%. NantHealth has a consensus price target of $4.75, indicating a potential upside of 691.67%. Given NantHealth’s stronger consensus rating and higher possible upside, analysts clearly believe NantHealth is more favorable than Zynga.


Zynga beats NantHealth on 10 of the 14 factors compared between the two stocks.

Zynga Company Profile

Zynga Inc. develops, markets, and operates social games as live services in the United States and internationally. The company's games are played on mobile platforms, such as iOS and Android operating systems, as well as on social networking sites, including Facebook. It also provides advertising services comprising mobile and display ads, engagement ads and offers, and branded virtual goods and sponsorships to advertising agencies and brokers; and software licensing and maintenance services related to NaturalMotion technology, as well as licenses its own brands. The company was formerly known as Zynga Game Network Inc. and changed its name to Zynga Inc. in November 2010. Zynga Inc. was founded in 2007 and is headquartered in San Francisco, California.

NantHealth Company Profile

NantHealth, Inc., together with its subsidiaries, operates as an evidence-based personalized healthcare company in the United States and internationally. The company engages in converging science and technology through an integrated clinical platform to provide health information at the point of care. It develops NantHealth solution, an adaptive learning system, including molecular profiling solution, software, and hardware systems infrastructure that collects, indexes, analyzes, and interprets various molecular, clinical, operational, and financial data points derived from various sources to enhance decision-making. The company's products include GPS Cancer, a molecular profile that integrates whole genome sequencing of tumor and normal germline samples, whole transcriptome sequencing, and quantitative proteomics; GPS Cancer Report, a GPS cancer solution; GPS in rare diseases and chronic illnesses; and Eviti, a decision support solution. It also provides Web-based and mobile software solutions, such as Device Connectivity Suite, a device connectivity and near real-time biometric software and hardware suite; DeviceConX, a device data normalization software; HBox, an Internet of Medical Things and Internet of Things hardware hub; and VitalsConX, a tablet-optimized application. In addition, NantHealth, Inc. offers NaviNet Open, a payer-provider collaboration platform comprising plan central, eligibility and benefit, claims status inquiry, claims management, referral, authorization, document exchange, and AllPayer services; and cloud-based computing, storage, and transport infrastructure-as-a-service solutions. The company was formerly known as Nant Health, LLC and changed its name to NantHealth, Inc. in June 2016. The company was founded in 2010 and is headquartered in Culver City, California. NantHealth, Inc. is as a subsidiary of NantWorks, LLC.

Receive News & Ratings for Zynga Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zynga and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply